MosaiQ™ COVID-19 Antibody Microarray
Quotient response to COVID-19
MosaiQ COVID-19 Antibody Microarray
Learn more

Latest updates

Quotient BIG Innovation award
News
Quotient Limited Wins 2021 BIG Innovation Award

JERSEY, Channel Islands, 12 January 2021(GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced it has been named a winner in the prestigious 2021 BIG Innovation Awards presented by the Business Intelligence Group.

Eysins, Switzerland Campus
News
Quotient Virtual Tour - Eysins, Switzerland

Bloodworks NW logo
News
MosaiQ at Bloodworks Northwest Seattle, WA

Take an insider look at how our MosaiQ instrument is used at Bloodworks Northwest, and hear what a Bloodworks technologist and a donor have to say about our technology: 

Virus
News
Quotient Limited Announces Receipt of U.S. FDA Emergency Use Authorization (EUA) for MosaiQ COVID-19 Antibody Test

JERSEY, Channel Islands, 28 September 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), headquartered in Eysins, Switzerland, today announced that on September 25, 2020, the U.S.

Quotient laboratory
News
Quotient Limited to Publish Quarterly Investor Presentation

JERSEY, Channel Islands, August 4, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today published the latest investor presentation associated with the earnings call for fiscal quarter ended June 30, 2020.

Quotient laboratory
News
Quotient Limited Reports First Quarter Fiscal 2021 Results and Business Update

•    Significant progress in three targeted areas of MosaiQ development – COVID-19 antibody test, potential new applications, and transfusion diagnostics 
•    Ten commercial placements of MosaiQ platform in Europe and the US

View all

Press releases

Quotient Limited Wins 2021 BIG Innovation Award
Read More
Quotient Limited Announces Departure of Chief Operating Officer
Read More
Read all press releases

Events

18 Nov
Jefferies Virtual London Healthcare Conference
Listen to webcast
View Presentation
See all events
Who we are
The future made possible.
Building on over 30 years of experience in transfusion diagnostics, we deliver game changing diagnostic solutions, empowering our customers to realize their full potential and improve their business.
Learn more
Investors
4:00 PM EDT • Jan 15, 2021
QTNT
6.06USD
-0.82%
3 Months
6 Months
12 Months
Quotient Ltd
$
Careers
Careers
Help us achieve our mission to transform transfusion diagnostics and beyond.
Joining Quotient is an opportunity to become part of a team that will shape the future of transfusion diagnostics.
Learn more
Reagents
Alba by Quotient. Experience. Expertise. Value.
These are just some of the qualities that set us apart from the competition. You can have peace of mind using our products, which have been time-tested for more than 30 years.
Learn more

Latest social posts